LUDLU-1Homo sapiens (Human)Cancer cell line

Also known as: LUDLU1, LUDLU 1, Ludlu-1

🤖 AI SummaryBased on 8 publications

Quick Overview

LUDLU-1 is a human lung squamous cell carcinoma cell line used in cancer research.

Detailed Summary

LUDLU-1 is a human lung squamous cell carcinoma cell line derived from a male patient. It is widely used in cancer research for studying the molecular mechanisms of squamous cell carcinoma. The cell line has been characterized for its genomic and transcriptomic profiles, including mutations in key genes such as TP53 and BRCA2. Research on LUDLU-1 has focused on understanding the role of somatic mutations, copy number variations, and gene expression in cancer progression. It has also been used to investigate the effects of DNA repair deficiencies and the potential for targeted therapies. The cell line is part of several large-scale studies, including the Cancer Cell Line Encyclopedia (CCLE) and the TRON Cell Line Portal, which provide comprehensive annotations of its genetic and molecular features.

Research Applications

Genomic and transcriptomic profilingMutation analysisDNA repair deficiency studiesTargeted therapy developmentCancer immunotherapy research

Key Characteristics

Mutations in TP53 and BRCA2Copy number variationsGene expression profilingHLA typing and neo-epitope predictionSomatic mutation analysis
Generated on 6/19/2025

Basic Information

Database IDCVCL_2582
SpeciesHomo sapiens (Human)

Donor Information

Age72
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseLung squamous cell carcinoma
LineageLung
SubtypeLung Squamous Cell Carcinoma
OncoTree CodeLUSC

DepMap Information

Source TypeECACC
Source IDACH-000390_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg248Trp (c.742C>T)HomozygousSomatic mutation acquired during proliferationfrom parent cell line VCaP

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
12
D16S539
13,14
D18S51
18
D21S11
28
D3S1358
16,18
D5S818
12
D7S820
10,12
D8S1179
8,15
FGA
25
Penta D
10
Penta E
12,19
TH01
6
TPOX
8,11
vWA
17,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing.

Wood H.M., Belvedere O., Papagiannopoulos K., Ryan A., Rabbitts P.H.

PLoS ONE 8:E78823-E78823(2013).

Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity.

Wu D., Pang Y., Wilkerson M.D., Wang D., Hammerman P.S., Liu J.S.

Br. J. Cancer 109:1599-1608(2013).

The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.

Papagiannopoulos K., Rabbitts P.H.

Neoplasia 14:1075-1086(2012).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Frequency and extent of allelic loss in the short arm of chromosome 3 in nonsmall-cell lung cancer.

Wells F., Albertson D.G., Waters J., Bergh J.

Genes Chromosomes Cancer 1:95-105(1989).